You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HG

Showing 1 - 25 of 5,531
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)

Completed
  • Healthy Participant
  • Changchun, Jilin, China
    The first hospital of Jilin University
Oct 11, 2023

COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)

Recruiting
  • COVID-19 Pneumonia
  • GST-HG171 Tablets
  • Changchun, Jilin, China
    The first hospital of Jilin University
Oct 26, 2023

COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)

Completed
  • COVID-19 Pneumonia
  • GST-HG171 Tablets
  • Changchun, Jilin, China
    The first hospital of Jilin University
Oct 26, 2023

COVID-19 Respiratory Infection Trial in Changchun (GST-HG171/ritonavir, ritonavir)

Active, not recruiting
  • COVID-19 Respiratory Infection
  • Changchun, Jilin, China
    The first hospital of Jilin University
Oct 10, 2023

Glabellar Lines Trial (Botulinum Toxin Type A Injection [HG102], Botulinum Toxin Type A Injection [Botox])

Not yet recruiting
  • Glabellar Lines
  • Botulinum Toxin Type A Injection [HG102]
  • Botulinum Toxin Type A Injection [Botox]
  • (no location specified)
Apr 5, 2023

Leber Congenital Amaurosis Trial (HG004)

Not yet recruiting
  • Leber Congenital Amaurosis
  • (no location specified)
Jun 13, 2023

COVID-19 Trial in Changchun (GST-HG171, of GST-HG171)

Recruiting
  • COVID-19
  • Changchun, Jilin, China
    The first hospital of Jilin University
Dec 25, 2022

COVID-19 Pneumonia Trial (GST-HG171/Ritonavir, Placebo)

Not yet recruiting
  • COVID-19 Pneumonia
  • (no location specified)
Dec 18, 2022

Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)

Recruiting
  • Glioma
  • +4 more
  • 3T MRI scanner
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Pharmacokinetics, Food Affect, Single Ascending Dose Trial in Changchun (GST-HG121 tablets, Placebo)

Recruiting
  • Pharmacokinetics
  • +3 more
  • GST-HG121 tablets
  • Placebo
  • Changchun, Jilin, China
    The first hospital of Jilin University
Dec 26, 2022

Chronic Hepatitis b Trial in Changchun (GST-HG141)

Recruiting
  • Chronic Hepatitis b
  • Changchun, Jilin, China
    The first hospital of Jilin University
Dec 5, 2022

Congenital Hearing Loss Trial in Shanghai (HG205)

Not yet recruiting
  • Congenital Hearing Loss
  • HG205
  • Shanghai, China
    Eye & ENT Hospital of Fudan University
Aug 29, 2023

Glabellar Lines Trial in Seoul (Botulinum Toxin Type A Injection [Botox], Botulinum toxin type A injection [HG-102])

Completed
  • Glabellar Lines
  • Botulinum Toxin Type A Injection [Botox]
  • Botulinum toxin type A injection [HG-102]
  • Seoul, Korea, Korea, Republic of
    Konkuk University Medical Center
May 23, 2022

Healthy Volunteers Trial in Fujian (GST-HG151, Placebo)

Recruiting
  • Healthy Volunteers
  • Fujian, Fuzhou, China
    Mengchao Hepatpbiliary Hospital of Fujian Medical University
Apr 19, 2022

Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration(nAMD)
  • HG202
  • Shanghai, Shanghai, China
  • +1 more
Sep 4, 2023

Multiple Myeloma, Relapsed and Refractory Multiple Myeloma Trial in Chengdu (HG146)

Recruiting
  • Multiple Myeloma
  • Relapsed and Refractory Multiple Myeloma
  • Chengdu, Sichuan, China
    HitGen Inc
Mar 16, 2022

Hepatitis B Trial in Changchun (GST-HG141 tablets, Matching Placebos for GST-HG141 tablets)

Completed
  • Hepatitis B
  • GST-HG141 tablets
  • Matching Placebos for GST-HG141 tablets
  • Changchun, Jilin, China
    The first hospital of Jilin University
Jun 6, 2022

Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias

Active, not recruiting
  • Telangiectasis
  • Polidocanol 0,2% + Hypertonic Glucose 70% (PDHG)
  • Botucatu, SP, Brazil
    Sao Paulo State University Botucatu Campus
May 5, 2023

Advanced Solid Tumor Trial in Chengdu (HG381)

Recruiting
  • Advanced Solid Tumor
  • Chengdu, Sichuan, China
    HitGen Inc.
Mar 17, 2022

Solid Tumor, Lymphoma Trial in Beijing (HG146, PD-(L)1 antibody)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Beijing, China
    National Cancer Center/Cancer Hospital
Mar 16, 2022

Brain Tumor Adult Trial in Salt Lake City (MR Perfusion Scan, 2HG Spectroscopy Scan)

Active, not recruiting
  • Brain Tumor Adult
  • MR Perfusion Scan
  • 2HG Spectroscopy Scan
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Nov 21, 2022

Kidney Tumors Treated With Minimally Invasive Surgery Trial in Bordeaux (Low insufflation pressure (7mm Hg) for Robotic Assisted

Recruiting
  • Kidney Tumors Treated With Minimally Invasive Surgery
  • Low insufflation pressure (7mm Hg) for Robotic Assisted Partial Nephrectomy
  • Standard insufflation pressure (12mm Hg) for Robotic Assisted Partial Nephrectomy
  • Angers, France
  • +14 more
Oct 27, 2022

Leber Congenital Amaurosis Trial in Shanghai (HG004)

Recruiting
  • Leber Congenital Amaurosis
  • HG004
  • Shanghai, Shanghai, China
    Xinhua Hospital affiliated with Shanghai Jiao Tong UniversitySch
Oct 12, 2023

Leber Congenital Amaurosis Trial in Shanghai (HG004)

Recruiting
  • Leber Congenital Amaurosis
  • HG004
  • Shanghai, Shanghai, China
    Xinhua Hospital affiliated with Shanghai Jiao Tong University Sc
Sep 26, 2023

Syncope, Vasovagal Trial in Tehran (Compression Stockings with 25-30 mm Hg pressure, Compression stockings with up to <=10 mm Hg

Recruiting
  • Syncope, Vasovagal
  • Compression Stockings with 25-30 mm Hg pressure
  • +2 more
  • Tehran, Iran, Islamic Republic of
    Tehran Heart Center
Apr 8, 2022